LEARNING CENTER

IN THE NEWS.

Heavy Hydrogen (Deuterium) in Living Organisms May Provide Clues to Prevent and Treat Cancer

http://www.b3cnewswire.com/201506151238/heavy-hydrogen-deuterium-in-living-organisms-may-provide-clues-to-prevent-and-treat-cancer.html

http://www.medicalnewstoday.com/releases/295522.php

http://ewallstreeter.com/heavy-hydrogen-deuterium-in-living-organisms-may-provide-clues-to-prevent-and-treat-cancer-8791/

https://mwl.wordpress.com/tag/pharma-news/

HYD Pharma Receives GMP Certification for Deuterium-Depleted Water (DDW) Production Facility

http://www.biospace.com/news_story.aspx?StoryID=389870&full=1

http://www.rndpipeline.com/News.aspx

http://www.topix.com/wire/world/p3

http://www.cphi-online.com/News

http://www.topix.com/health/leukemia/2015/09/hyd-pharma-receives-gmp-certification-for-deuterium-depleted-water-ddw-production-facility

http://www.pharmaasia.com/article/hyd-pharma-receives-gmp-certification-for-deuterium-depleted-water-production-facility/11970

http://pharmaceuticals.einnews.com/pr_news/284282761/hyd-pharma-receives-gmp-certification-for-deuterium-depleted-water-ddw-production-facility

http://www.checkorphan.org/news/hyd-pharma-receives-gmp-certification-for-deuterium-depleted-water-ddw-production-facility

http://www.newsfiber.com/p/s/h?s=21&v=C%2FBusiness%2FIndustry%2FPharmaceutics%2F&n=zzz&y=

B3C HYD Pharma Receives Ethical Approval for Phase 2 Clinical Trial Investigating the Anticancer Effect of Deuterium Depletion in CLL

https://healthunlocked.com/cllsupport/posts/133858035/anticancer-effect-of-deuterium-depleted-water-ddw-in-cll

https://pipelinereview.com/index.php/2016071861858/Small-Molecules/HYD-Pharma-Receives-Ethical-Approval-for-Phase-2-Clinical-Trial-Investigating-the-Anticancer-Effect-of-Deuterium-Depletion-in-CLL.html

http://www.einnews.com/pr_news/335585394/hyd-pharma-receives-ethical-approval-for-phase-2-clinical-trial-investigating-the-anticancer-effect-of-deuterium-depletion-in-cll

http://www.rndpipeline.com/News.aspx

http://www.pharmavoice.com/newsreleases/hyd-pharma-receives-ethical-approval-phase-2-clinical-trial-investigating-anticancer-effect-deuterium-depletion-cll/